Leading European venture capital firm exceeds €4 billion in assets under management, doubling its AUM in the last five years PARIS, France – March 4, 2025 — Sofinnova Partners (“Sofinnova”), a leading European venture capital firm in life sciences based in Paris, London, and Milan, today announced it had raised €1.2 billion across its platform […]
OZEMPIC, Wegovy, Mounjaro, Zepbound: they’ve quickly become part of our vocabulary. In just a few years, powerful GLP-1 drugs, first introduced to control Type 2 diabetes but now much better known for their ability to help people rapidly lose weight, have become indispensable weapons in the Battle of the Bulge. In the UK alone, some […]
Investment firms The Novo Nordisk Foundation has allocated up to DKK 5.5 billion (EUR 736 million) to BioInnovation Institute (BII) to enable BII to expand its activities into new strategic areas and geographies, and support more entrepreneurs and start-up-companies Andreessen Horowitz has raised more than $15 billion across five new funds with $700 million of that proportioned off to its ‘Bio + Health’ fund. Servier announced the […]
#AI has been making the headlines again this week, with a bold announcement from the UK government that it could be used to fix the many potholes that pepper Britain’s roads. But beyond politics, there’s an ongoing narrative in life sciences about the growing role of AI across the clinical development process. Perhaps the most […]
Where has the time gone? We are now in 2025, and industry events are quickly approaching. If you are still gathering your thoughts on how best to maximise your events calendar this year, allow us to flag some of the ‘must-attend’ Healthcare conferences of Winter/Spring 2025. January is for JPM The 43rd JPM Annual Healthcare […]
